These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation. Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104 [No Abstract] [Full Text] [Related]
15. Long-term outcome of cadaveric kidney grafts with triple drug therapy. Amemiya H; Suzuki S; Hayashi R; Nakatani T Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683 [No Abstract] [Full Text] [Related]
16. Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan. Takahashi K; Takahara S; Uchida K; Yoshimura N; Toma H; Oshima S; Sonoda T; Transplant Proc; 2005 May; 37(4):1800-3. PubMed ID: 15919471 [TBL] [Abstract][Full Text] [Related]
17. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years. MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774 [No Abstract] [Full Text] [Related]